Canada markets open in 6 hours 10 minutes

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.87-0.74 (-5.44%)
At close: 04:00PM EDT
12.87 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 597.11M
Enterprise Value 519.89M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.00
Price/Book (mrq)5.91
Enterprise Value/Revenue 6.13
Enterprise Value/EBITDA -20.85

Trading Information

Stock Price History

Beta (5Y Monthly) 0.77
52-Week Change 343.16%
S&P500 52-Week Change 326.43%
52 Week High 320.90
52 Week Low 34.60
50-Day Moving Average 315.62
200-Day Moving Average 39.42

Share Statistics

Avg Vol (3 month) 3390.14k
Avg Vol (10 day) 3436.77k
Shares Outstanding 543.87M
Implied Shares Outstanding 646.4M
Float 825.48M
% Held by Insiders 114.51%
% Held by Institutions 165.97%
Shares Short (Apr 15, 2024) 42.33M
Short Ratio (Apr 15, 2024) 46.85
Short % of Float (Apr 15, 2024) 46.38%
Short % of Shares Outstanding (Apr 15, 2024) 45.32%
Shares Short (prior month Mar 15, 2024) 42.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -25.64%
Operating Margin (ttm)-34.66%

Management Effectiveness

Return on Assets (ttm)-12.02%
Return on Equity (ttm)-20.93%

Income Statement

Revenue (ttm)84.5M
Revenue Per Share (ttm)1.93
Quarterly Revenue Growth (yoy)-1.60%
Gross Profit (ttm)N/A
EBITDA -24.37M
Net Income Avi to Common (ttm)-21.67M
Diluted EPS (ttm)-0.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)75.75M
Total Cash Per Share (mrq)1.73
Total Debt (mrq)1.18M
Total Debt/Equity (mrq)1.19%
Current Ratio (mrq)6.15
Book Value Per Share (mrq)2.26

Cash Flow Statement

Operating Cash Flow (ttm)-17.59M
Levered Free Cash Flow (ttm)-11.46M